Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) was the target of a significant drop in short interest in the month of December. As of December 29th, there was short interest totalling 12,798,732 shares, a drop of 17.3% from the December 15th total of 15,484,326 shares. Approximately 7.2% of the company’s shares are sold short. Based on an average trading volume of 1,613,629 shares, the days-to-cover ratio is presently 7.9 days.

MDRX has been the topic of a number of recent research reports. Royal Bank of Canada initiated coverage on shares of Allscripts Healthcare Solutions in a research note on Tuesday, September 19th. They set an “outperform” rating and a $17.00 price objective on the stock. Cantor Fitzgerald reiterated a “buy” rating and set a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Wednesday, September 27th. Dougherty & Co reiterated a “buy” rating and set a $16.00 price objective (up from $15.00) on shares of Allscripts Healthcare Solutions in a research note on Tuesday, October 3rd. Zacks Investment Research downgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Tuesday, October 10th. Finally, Robert W. Baird reiterated a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Tuesday, October 17th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and twelve have given a buy rating to the company. Allscripts Healthcare Solutions currently has a consensus rating of “Buy” and a consensus target price of $15.53.

Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at $16.03 on Tuesday. The firm has a market cap of $2,900.00, a P/E ratio of -13.82, a price-to-earnings-growth ratio of 2.27 and a beta of 1.32. Allscripts Healthcare Solutions has a one year low of $11.01 and a one year high of $16.13. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.20.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its earnings results on Thursday, November 2nd. The software maker reported $0.12 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.12. Allscripts Healthcare Solutions had a negative net margin of 12.23% and a positive return on equity of 6.53%. equities research analysts anticipate that Allscripts Healthcare Solutions will post 0.46 EPS for the current year.

In other news, SVP James Hewitt sold 36,796 shares of the stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $14.11, for a total transaction of $519,191.56. Following the transaction, the senior vice president now directly owns 181,766 shares in the company, valued at $2,564,718.26. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Brian Farley sold 5,000 shares of the stock in a transaction that occurred on Thursday, December 14th. The shares were sold at an average price of $14.35, for a total transaction of $71,750.00. Following the transaction, the executive vice president now owns 191,607 shares in the company, valued at $2,749,560.45. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 56,796 shares of company stock worth $804,842. Corporate insiders own 0.91% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in MDRX. Prudential Financial Inc. boosted its stake in Allscripts Healthcare Solutions by 9.3% in the second quarter. Prudential Financial Inc. now owns 122,355 shares of the software maker’s stock valued at $1,561,000 after acquiring an additional 10,438 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of Allscripts Healthcare Solutions by 4.5% during the second quarter. Principal Financial Group Inc. now owns 771,481 shares of the software maker’s stock worth $9,844,000 after buying an additional 33,059 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of Allscripts Healthcare Solutions by 0.4% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,484 shares of the software maker’s stock worth $338,000 after buying an additional 115 shares during the period. Northwestern Mutual Investment Management Company LLC lifted its stake in shares of Allscripts Healthcare Solutions by 3.8% during the second quarter. Northwestern Mutual Investment Management Company LLC now owns 32,297 shares of the software maker’s stock worth $410,000 after buying an additional 1,189 shares during the period. Finally, Systematic Financial Management LP lifted its stake in shares of Allscripts Healthcare Solutions by 6.4% during the second quarter. Systematic Financial Management LP now owns 140,905 shares of the software maker’s stock worth $1,798,000 after buying an additional 8,450 shares during the period.

WARNING: This story was originally published by Daily Political and is owned by of Daily Political. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.dailypolitical.com/2018/01/15/short-interest-in-allscripts-healthcare-solutions-inc-mdrx-drops-by-17-3.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.